Drug Profile
BCL 5
Alternative Names: BCL-5Latest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator Botanic Century
- Class
- Mechanism of Action Glucosidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Type 2 diabetes mellitus
Most Recent Events
- 06 Sep 2023 BCL 5 is still in preclinical development for Type-2 diabetes mellitus in China (Botanic Century pipeline, September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in China
- 19 Jul 2016 Preclinical trials in Type-2 diabetes mellitus in China (unspecified route)